首页 > 最新文献

Geburtshilfe Und Frauenheilkunde最新文献

英文 中文
Novel Antibody-Drug-Conjugates in Routine Clinical Practice for the Treatment of Metastatic Breast Cancer: Adherence, Efficacy and Tolerability - Real-World Data from German Breast Centers. 常规临床实践中用于治疗转移性乳腺癌的新型抗体药物轭合物:依从性、疗效和耐受性--来自德国乳腺中心的真实世界数据。
IF 2.4 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-02 eCollection Date: 2024-09-01 DOI: 10.1055/a-2375-5194
Henning Schäffler, Dorothee Jakob, Sophia Huesmann, Kerstin Pfister, Kristina Veselinovic, Fabienne Schochter, Elena Leinert, Visnja Fink, Brigitte Rack, Alexander Englisch, Lea-Louise Volmer, Tobias Engler, Marie Louise Frevert, Ingolf Juhasz-Böss, Sara Brucker, Sabine Heublein, Wolfgang Janni, Florin-Andrei Taran, Andreas Hartkopf, Dominik Dannehl

Introduction: The third-generation antibody-drug conjugates (ADC), trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG), recently obtained approval for metastatic breast cancer treatment across various subtypes and therapeutic contexts.

Materials and methods: This retrospective, multicentric study evaluated real-world tolerability, feasibility and efficacy in a pre-treated, real-world cohort at three major German breast cancer centers.

Results: 125 patients treated with T-DXd or SG from November 2020 to June 2023 were included (T-DXd: 77 patients; SG: 48 patients). The median treatment duration was 6.0 months for T-DXd and 3.5 months for SG therapy, with a median follow-up duration of 10.4 months for T-DXd (95% CI: 8.4-11.6) and 11.8 months for SG (95% CI: 8.0-14.4). Severe neutropenia (CTC ≥ III°) occurred in 33.3% during SG therapy, with a numerical reduction observed following primary, prophylactic use of G-CSF. T-DXd-associated pneumonitis occurred in 8 out of 77 patients (10.4 %). Median progression-free survival (mPFS) was 8.6 months (95% CI: 5.8-12.4) with T-DXd (HER2+: 10.8; HER2-low: 4.7) and 4.9 months (95% CI: 2.8-6.3) with SG (TNBC 4.9; HR+/HER2-: not reached). Median overall survival (OS) was 23.8 months (95% CI: 16.1-not estimable) with T-DXd (HER2+: 27.1; HER2-low: not reached), and 12.4 months (95% CI: 8.7-not estimable) with SG therapy (TNBC: 12.4, HR+/HER2-: not reached). 95.7% of the protocol-specified, therapeutic dose was administered for T-DXd and 89.6% for SG.

Conclusion: Overall, this indicates good feasibility, tolerability, and effectiveness of ADC therapies in the real-world setting.

导言:第三代抗体药物共轭物(ADC)--曲妥珠单抗德鲁司坦(T-DXd)和萨希珠单抗戈维替康(SG)最近获批用于不同亚型和治疗背景下的转移性乳腺癌治疗:这项回顾性多中心研究评估了德国三大乳腺癌中心预先治疗的真实世界队列的耐受性、可行性和疗效:纳入了2020年11月至2023年6月期间接受T-DXd或SG治疗的125例患者(T-DXd:77例;SG:48例)。T-DXd的中位治疗时间为6.0个月,SG的中位治疗时间为3.5个月,T-DXd的中位随访时间为10.4个月(95% CI:8.4-11.6),SG的中位随访时间为11.8个月(95% CI:8.0-14.4)。在 SG 治疗期间,33.3% 的患者出现了严重的中性粒细胞减少症(CTC ≥ III°),而在主要预防性使用 G-CSF 后,这一数字有所下降。77 例患者中有 8 例(10.4%)发生了 T-DXd 相关性肺炎。T-DXd的中位无进展生存期(mPFS)为8.6个月(95% CI:5.8-12.4)(HER2+:10.8;HER2-low:4.7),SG的中位无进展生存期(mPFS)为4.9个月(95% CI:2.8-6.3)(TNBC:4.9;HR+/HER2-:未达到)。T-DXd疗法的中位总生存期(OS)为23.8个月(95% CI:16.1个月,无法估计)(HER2+:27.1个月;HER2-low:未达到),SG疗法的中位总生存期(OS)为12.4个月(95% CI:8.7个月,无法估计)(TNBC:12.4个月;HR+/HER2-:未达到)。T-DXd和SG的治疗剂量分别达到了方案规定的95.7%和89.6%:总体而言,这表明 ADC 疗法在现实世界中具有良好的可行性、耐受性和有效性。
{"title":"Novel Antibody-Drug-Conjugates in Routine Clinical Practice for the Treatment of Metastatic Breast Cancer: Adherence, Efficacy and Tolerability - Real-World Data from German Breast Centers.","authors":"Henning Schäffler, Dorothee Jakob, Sophia Huesmann, Kerstin Pfister, Kristina Veselinovic, Fabienne Schochter, Elena Leinert, Visnja Fink, Brigitte Rack, Alexander Englisch, Lea-Louise Volmer, Tobias Engler, Marie Louise Frevert, Ingolf Juhasz-Böss, Sara Brucker, Sabine Heublein, Wolfgang Janni, Florin-Andrei Taran, Andreas Hartkopf, Dominik Dannehl","doi":"10.1055/a-2375-5194","DOIUrl":"10.1055/a-2375-5194","url":null,"abstract":"<p><strong>Introduction: </strong>The third-generation antibody-drug conjugates (ADC), trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG), recently obtained approval for metastatic breast cancer treatment across various subtypes and therapeutic contexts.</p><p><strong>Materials and methods: </strong>This retrospective, multicentric study evaluated real-world tolerability, feasibility and efficacy in a pre-treated, real-world cohort at three major German breast cancer centers.</p><p><strong>Results: </strong>125 patients treated with T-DXd or SG from November 2020 to June 2023 were included (T-DXd: 77 patients; SG: 48 patients). The median treatment duration was 6.0 months for T-DXd and 3.5 months for SG therapy, with a median follow-up duration of 10.4 months for T-DXd (95% CI: 8.4-11.6) and 11.8 months for SG (95% CI: 8.0-14.4). Severe neutropenia (CTC ≥ III°) occurred in 33.3% during SG therapy, with a numerical reduction observed following primary, prophylactic use of G-CSF. T-DXd-associated pneumonitis occurred in 8 out of 77 patients (10.4 %). Median progression-free survival (mPFS) was 8.6 months (95% CI: 5.8-12.4) with T-DXd (HER2+: 10.8; HER2-low: 4.7) and 4.9 months (95% CI: 2.8-6.3) with SG (TNBC 4.9; HR+/HER2-: not reached). Median overall survival (OS) was 23.8 months (95% CI: 16.1-not estimable) with T-DXd (HER2+: 27.1; HER2-low: not reached), and 12.4 months (95% CI: 8.7-not estimable) with SG therapy (TNBC: 12.4, HR+/HER2-: not reached). 95.7% of the protocol-specified, therapeutic dose was administered for T-DXd and 89.6% for SG.</p><p><strong>Conclusion: </strong>Overall, this indicates good feasibility, tolerability, and effectiveness of ADC therapies in the real-world setting.</p>","PeriodicalId":12481,"journal":{"name":"Geburtshilfe Und Frauenheilkunde","volume":"84 9","pages":"855-865"},"PeriodicalIF":2.4,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11368468/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142125351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic Impact of Surgical Margin Status on Overall Survival of Patients with Early Breast Cancer: A Retrospective Analysis from the Department for Women's Medicine at Charité - University Hospital Berlin. 手术边缘状态对早期乳腺癌患者总生存期的预后影响:柏林夏里特大学医院妇女医学部的回顾性分析。
IF 2.4 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-02 eCollection Date: 2024-09-01 DOI: 10.1055/a-2374-2270
Maximilian Heinz Beck, Karoline Barbara Stephanie Weiler, Anna Trelinska-Finger, Jens-Uwe Blohmer

Introduction: The impact of surgical margins on the prognosis of early breast cancer remains uncertain, particularly in the context of modern treatment approaches. This study aimed to investigate whether involved margins after surgery for early breast cancer affect overall survival.

Methods: We conducted a retrospective analysis of 3767 patients who underwent surgery for primary breast cancer or carcinoma in situ between 2006 and 2022 at Charité - University Hospital Berlin. Survival analysis based on margin status and a subsequent multivariate Cox regression analysis were conducted.

Results: With a median follow-up of 72.2 months, clear margins were achieved in 81.4% of patients (n = 3068) after primary surgery, while 16.2% (n = 610) required re-excision. Only 2.4% of patients (n = 89) had definitively involved margins. Margin involvement was more common in hormone receptor-positive disease, lobular subtype, carcinoma in situ, or locally advanced tumors, but less frequent in patients with previous neoadjuvant chemotherapy or triple-negative breast cancer. The Kaplan-Meier survival curves showed a significant separation with worse outcomes for patients with definitive R1 resections. However, the multivariate Cox regression analysis detected no statistically significant difference in overall survival based on margin status. Breast conserving surgery (HR 0.66; 95% CI 0.54-0.81) and HER2 overexpression (HR 0.65; 95% CI 0.48-0.89) were associated with improved survival.

Conclusion: Patients who underwent breast-conserving surgery in our study demonstrated favorable outcomes compared to patients after mastectomy. Although margin status did not significantly affect overall survival, larger multicenter studies are needed to evaluate the prognostic implications of margin involvement in breast cancer treatment in different tumor stages, tumor subtypes and local and systemic treatments.

导言:手术边缘对早期乳腺癌预后的影响仍不确定,尤其是在现代治疗方法的背景下。本研究旨在探讨早期乳腺癌手术后受累边缘是否会影响总生存率:我们对 2006 年至 2022 年期间在柏林夏里特大学医院接受原发性乳腺癌或原位癌手术的 3767 名患者进行了回顾性分析。我们根据边缘状态进行了生存分析,并随后进行了多变量 Cox 回归分析:中位随访时间为72.2个月,81.4%的患者(n = 3068)在初次手术后边缘清晰,16.2%的患者(n = 610)需要再次切除。只有 2.4% 的患者(n = 89)的边缘明确受累。边缘受累在激素受体阳性疾病、小叶亚型、原位癌或局部晚期肿瘤中更为常见,但在曾接受新辅助化疗或三阴性乳腺癌患者中则较少见。Kaplan-Meier生存曲线显示,明确R1切除的患者预后较差。然而,多变量考克斯回归分析发现,边缘状态对总生存率的影响在统计学上没有显著差异。保乳手术(HR 0.66; 95% CI 0.54-0.81)和HER2过表达(HR 0.65; 95% CI 0.48-0.89)与生存率的提高有关:结论:在我们的研究中,与接受乳房切除术的患者相比,接受保乳手术的患者的预后较好。尽管边缘状态对总生存率没有明显影响,但仍需进行更大规模的多中心研究,以评估边缘受累对不同肿瘤分期、肿瘤亚型以及局部和全身治疗的乳腺癌治疗的预后影响。
{"title":"Prognostic Impact of Surgical Margin Status on Overall Survival of Patients with Early Breast Cancer: A Retrospective Analysis from the Department for Women's Medicine at Charité - University Hospital Berlin.","authors":"Maximilian Heinz Beck, Karoline Barbara Stephanie Weiler, Anna Trelinska-Finger, Jens-Uwe Blohmer","doi":"10.1055/a-2374-2270","DOIUrl":"10.1055/a-2374-2270","url":null,"abstract":"<p><strong>Introduction: </strong>The impact of surgical margins on the prognosis of early breast cancer remains uncertain, particularly in the context of modern treatment approaches. This study aimed to investigate whether involved margins after surgery for early breast cancer affect overall survival.</p><p><strong>Methods: </strong>We conducted a retrospective analysis of 3767 patients who underwent surgery for primary breast cancer or carcinoma in situ between 2006 and 2022 at Charité - University Hospital Berlin. Survival analysis based on margin status and a subsequent multivariate Cox regression analysis were conducted.</p><p><strong>Results: </strong>With a median follow-up of 72.2 months, clear margins were achieved in 81.4% of patients (n = 3068) after primary surgery, while 16.2% (n = 610) required re-excision. Only 2.4% of patients (n = 89) had definitively involved margins. Margin involvement was more common in hormone receptor-positive disease, lobular subtype, carcinoma in situ, or locally advanced tumors, but less frequent in patients with previous neoadjuvant chemotherapy or triple-negative breast cancer. The Kaplan-Meier survival curves showed a significant separation with worse outcomes for patients with definitive R1 resections. However, the multivariate Cox regression analysis detected no statistically significant difference in overall survival based on margin status. Breast conserving surgery (HR 0.66; 95% CI 0.54-0.81) and HER2 overexpression (HR 0.65; 95% CI 0.48-0.89) were associated with improved survival.</p><p><strong>Conclusion: </strong>Patients who underwent breast-conserving surgery in our study demonstrated favorable outcomes compared to patients after mastectomy. Although margin status did not significantly affect overall survival, larger multicenter studies are needed to evaluate the prognostic implications of margin involvement in breast cancer treatment in different tumor stages, tumor subtypes and local and systemic treatments.</p>","PeriodicalId":12481,"journal":{"name":"Geburtshilfe Und Frauenheilkunde","volume":"84 9","pages":"837-844"},"PeriodicalIF":2.4,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11368467/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142125362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to: Letter to the Editor: Administration of Antenatal Corticosteroids: Optimal Timing. 答复致编辑的信:产前皮质类固醇的使用:最佳时间。
IF 2.4 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-02 eCollection Date: 2024-09-01 DOI: 10.1055/a-2342-5218
Richard Berger, Patrick Stelzl, Holger Maul
{"title":"Reply to: Letter to the Editor: Administration of Antenatal Corticosteroids: Optimal Timing.","authors":"Richard Berger, Patrick Stelzl, Holger Maul","doi":"10.1055/a-2342-5218","DOIUrl":"10.1055/a-2342-5218","url":null,"abstract":"","PeriodicalId":12481,"journal":{"name":"Geburtshilfe Und Frauenheilkunde","volume":"84 9","pages":"877"},"PeriodicalIF":2.4,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11368460/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142125363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor: Administration of Antenatal Corticosteroids: Optimal Timing. 致编辑的信:产前皮质类固醇的使用:最佳时间。
IF 2.4 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-02 eCollection Date: 2024-09-01 DOI: 10.1055/a-2328-9427
Themistoklis Dagklis, Cihat Sen
{"title":"Letter to the Editor: Administration of Antenatal Corticosteroids: Optimal Timing.","authors":"Themistoklis Dagklis, Cihat Sen","doi":"10.1055/a-2328-9427","DOIUrl":"10.1055/a-2328-9427","url":null,"abstract":"","PeriodicalId":12481,"journal":{"name":"Geburtshilfe Und Frauenheilkunde","volume":"84 9","pages":"876"},"PeriodicalIF":2.4,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11368461/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142125350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Palbociclib: Randomized Studies and Real-world Evidence as the Basis for Therapeutic Planning in Metastatic Breast Cancer. 帕博西尼(Palbociclib):作为转移性乳腺癌治疗计划基础的随机研究和现实世界的证据。
IF 2.4 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-02 eCollection Date: 2024-09-01 DOI: 10.1055/a-2344-5269
Eugen Ruckhäberle, Marcus Schmidt, Anja Welt, Nadia Harbeck, Achim Wöckel, Oleg Gluz, Tjoung-Won Park-Simon, Michael Untch, Michael P Lux

Endocrine-based combination therapy with an inhibitor of the cyclin-dependent kinases 4 and 6 (CDK4/6 inhibitors) is currently the first-line therapy of choice for patients with hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2-), locally advanced or metastatic breast cancer (mBC). The efficacy and safety of the treatment with palbociclib, the first CDK4/6 inhibitor approved for this indication, have been confirmed in large randomized controlled clinical trials (RCTs) with strictly defined patient cohorts. Since then, many relevant questions about CDK4/6 inhibition with palbociclib for mBC have been investigated in RCTs and real-world studies. Based on this evidence, palbociclib is widely used in clinical practice since many years because of its efficacy and good tolerability. The aim of this review is to summarize findings from RCTs and RWE considering clinically relevant aspects such as safety, tolerability, quality of life and efficacy with a focus on specific questions and patient characteristics. A critical discussion and review of the overall evidence for endocrine-based therapy with the CDK4/6 inhibitor palbociclib can contribute to support therapy decisions in daily clinical practice.

对于激素受体阳性(HR+)、人表皮生长因子受体 2 阴性(HER2-)、局部晚期或转移性乳腺癌(mBC)患者,以内分泌为基础的联合疗法和细胞周期蛋白依赖性激酶 4 和 6 抑制剂(CDK4/6 抑制剂)是目前的一线首选疗法。帕博西尼(palbociclib)是首个获批用于该适应症的CDK4/6抑制剂,其治疗的有效性和安全性已在严格界定患者队列的大型随机对照临床试验(RCT)中得到证实。从那时起,许多与使用帕博西尼(palbociclib)抑制 CDK4/6 治疗 mBC 相关的问题都在 RCT 和实际研究中得到了探讨。基于这些证据,多年来,palbociclib 凭借其疗效和良好的耐受性被广泛应用于临床实践。本综述旨在总结 RCT 和 RWE 的研究结果,考虑与临床相关的方面,如安全性、耐受性、生活质量和疗效,重点关注具体问题和患者特征。对以CDK4/6抑制剂palbociclib为基础的内分泌治疗的总体证据进行批判性讨论和综述,有助于支持日常临床实践中的治疗决策。
{"title":"Palbociclib: Randomized Studies and Real-world Evidence as the Basis for Therapeutic Planning in Metastatic Breast Cancer.","authors":"Eugen Ruckhäberle, Marcus Schmidt, Anja Welt, Nadia Harbeck, Achim Wöckel, Oleg Gluz, Tjoung-Won Park-Simon, Michael Untch, Michael P Lux","doi":"10.1055/a-2344-5269","DOIUrl":"10.1055/a-2344-5269","url":null,"abstract":"<p><p>Endocrine-based combination therapy with an inhibitor of the cyclin-dependent kinases 4 and 6 (CDK4/6 inhibitors) is currently the first-line therapy of choice for patients with hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2-), locally advanced or metastatic breast cancer (mBC). The efficacy and safety of the treatment with palbociclib, the first CDK4/6 inhibitor approved for this indication, have been confirmed in large randomized controlled clinical trials (RCTs) with strictly defined patient cohorts. Since then, many relevant questions about CDK4/6 inhibition with palbociclib for mBC have been investigated in RCTs and real-world studies. Based on this evidence, palbociclib is widely used in clinical practice since many years because of its efficacy and good tolerability. The aim of this review is to summarize findings from RCTs and RWE considering clinically relevant aspects such as safety, tolerability, quality of life and efficacy with a focus on specific questions and patient characteristics. A critical discussion and review of the overall evidence for endocrine-based therapy with the CDK4/6 inhibitor palbociclib can contribute to support therapy decisions in daily clinical practice.</p>","PeriodicalId":12481,"journal":{"name":"Geburtshilfe Und Frauenheilkunde","volume":"84 9","pages":"813-836"},"PeriodicalIF":2.4,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11368471/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142125361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How to Play a Game Properly - Enhancing Obstetrics and Gynecology Education through Gamification: A Scoping Review. 如何正确地玩游戏-通过游戏化加强妇产科教育:范围审查。
IF 2.4 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-27 eCollection Date: 2024-12-01 DOI: 10.1055/a-2379-8729
Melissa Neubacher, Pauline Siebers, Agnes Wittek, Florian Recker

Background: Effective healthcare relies on well-trained professionals, and the quality of their training is dependent on appropriate learning methods and assessment techniques. Gamification, the use of game mechanics in non-game environments, has emerged as a promising strategy in medical education. This review explores the applicability and effectiveness of gamification in obstetrics and gynecology education.

Methods: Adhering to PRISMA guidelines, a comprehensive search was conducted on PubMed, Google Scholar, Embase, and Medline databases from January to March 2023. The search terms included "medical students OR residents OR physicians OR midwives AND games OR educational games OR serious games AND gynecology OR obstetrics". The inclusion criteria encompassed studies published in English or German from 1990 to March 2023, focusing on gamification in gynecology and obstetrics education. Data extraction and analysis were structured using the PICOS framework.

Results: The review identified various studies demonstrating the effectiveness of gamification in obstetrics and gynecology education. Gaming shows like Jeopardy significantly boosted knowledge retention and engagement. VR technologies, such as Second Life, enhanced emergency and surgical training. Improvisational games improved empathy skills, though requiring reinforcement. Video games and laparoscopy trainers showed promise in enhancing surgical skills, with gamers performing better in initial tasks. Custom-developed games like Play and Learn for Surgeons significantly improved procedural skills.

Discussion: Gamification in obstetrics and gynecology education boosts learner engagement, knowledge retention, and practical skills. VR technologies and video games are effective for surgical training, while custom games can enhance specific procedural skills. Further research is needed to optimize and integrate gamification strategies into standard curricula, offering a modern approach to equip healthcare professionals with essential skills and knowledge.

背景:有效的医疗保健依赖于训练有素的专业人员,他们的培训质量取决于适当的学习方法和评估技术。游戏化,即在非游戏环境中使用游戏机制,已经成为医学教育中一种很有前途的策略。本文综述了游戏化在妇产科教育中的适用性和有效性。方法:遵循PRISMA指南,于2023年1 - 3月对PubMed、谷歌Scholar、Embase和Medline数据库进行全面检索。搜索词包括“医学院学生、住院医生、医生、助产士、游戏、教育游戏、严肃游戏、妇产科学”。纳入标准包括1990年至2023年3月期间以英语或德语发表的研究,重点关注妇产科教育中的游戏化。数据提取和分析采用PICOS框架进行结构化。结果:本综述确定了证明游戏化在妇产科教育中的有效性的各种研究。《危险边缘》等游戏节目显著提高了知识留存率和参与度。虚拟现实技术,如第二人生,加强了急救和外科训练。即兴游戏提高了同理心技能,尽管需要强化。视频游戏和腹腔镜训练师有望提高手术技能,玩家在最初的任务中表现更好。自定义开发的游戏,如“外科医生的游戏和学习”,显著提高了手术技能。讨论:游戏化在妇产科教育提高学习者的参与,知识的保留,和实践技能。VR技术和视频游戏对外科训练很有效,而定制游戏可以提高特定的手术技能。需要进一步的研究来优化并将游戏化策略整合到标准课程中,提供一种现代化的方法来为医疗保健专业人员提供基本的技能和知识。
{"title":"How to Play a Game Properly - Enhancing Obstetrics and Gynecology Education through Gamification: A Scoping Review.","authors":"Melissa Neubacher, Pauline Siebers, Agnes Wittek, Florian Recker","doi":"10.1055/a-2379-8729","DOIUrl":"10.1055/a-2379-8729","url":null,"abstract":"<p><strong>Background: </strong>Effective healthcare relies on well-trained professionals, and the quality of their training is dependent on appropriate learning methods and assessment techniques. Gamification, the use of game mechanics in non-game environments, has emerged as a promising strategy in medical education. This review explores the applicability and effectiveness of gamification in obstetrics and gynecology education.</p><p><strong>Methods: </strong>Adhering to PRISMA guidelines, a comprehensive search was conducted on PubMed, Google Scholar, Embase, and Medline databases from January to March 2023. The search terms included \"medical students OR residents OR physicians OR midwives AND games OR educational games OR serious games AND gynecology OR obstetrics\". The inclusion criteria encompassed studies published in English or German from 1990 to March 2023, focusing on gamification in gynecology and obstetrics education. Data extraction and analysis were structured using the PICOS framework.</p><p><strong>Results: </strong>The review identified various studies demonstrating the effectiveness of gamification in obstetrics and gynecology education. Gaming shows like Jeopardy significantly boosted knowledge retention and engagement. VR technologies, such as Second Life, enhanced emergency and surgical training. Improvisational games improved empathy skills, though requiring reinforcement. Video games and laparoscopy trainers showed promise in enhancing surgical skills, with gamers performing better in initial tasks. Custom-developed games like Play and Learn for Surgeons significantly improved procedural skills.</p><p><strong>Discussion: </strong>Gamification in obstetrics and gynecology education boosts learner engagement, knowledge retention, and practical skills. VR technologies and video games are effective for surgical training, while custom games can enhance specific procedural skills. Further research is needed to optimize and integrate gamification strategies into standard curricula, offering a modern approach to equip healthcare professionals with essential skills and knowledge.</p>","PeriodicalId":12481,"journal":{"name":"Geburtshilfe Und Frauenheilkunde","volume":"84 12","pages":"1126-1134"},"PeriodicalIF":2.4,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11623999/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142793910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Value of Cerebroplacental Ratio in Predicting Adverse Perinatal Outcome in Term Pregnancies Complicated by Obesity. 预测肥胖症并发的足月妊娠不良围产期结果的脑-胎盘比率的价值
IF 2.4 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-22 eCollection Date: 2024-11-01 DOI: 10.1055/a-2373-0722
Gabriel Eisenkolb, Anne Karge, Javier U Ortiz, Eva Ostermayer, Silvia M Lobmaier, Bettina Kuschel, Oliver Graupner

Objectives: To evaluate the performance of cerebroplacental ratio (CPR) in predicting composite adverse perinatal outcome (CAPO) in women with obesity compared to non-obese women at term.

Methods: This is a retrospective cohort study in a single tertiary referral centre over a 3-year period. All singleton pregnancies with CPR measurements ≥ 37 + 0 weeks and estimated fetal weight ≥ 10 th centile and attempted vaginal delivery were included and divided into two groups defined by pre-pregnancy body mass index (BMI) 2 . The presence of at least one of the following outcome parameters was defined as CAPO: operative delivery (OD) due to intrapartum fetal compromise (IFC), admission to the neonatal intensive care unit, umbilical cord arterial pH ≤ 7.15, 5 min Apgar < 7. The prognostic performance of CPR MoM was evaluated using receiver operating characteristic (ROC) analysis.

Results: The study cohort included 1207 pregnancies, of which 112 were women with a BMI ≥ 30 kg/m 2 . In obese women, CAPO occurred in 21 cases (18.8%) compared to 247 (22.6%) cases in women with BMI < 30 kg/m 2 (p = 0.404). In the entire study cohort, CPR MoM was significantly lower in the CAPO and OD for IFC group. ROC analyses revealed a significant predictive value of low CPR MoM for CAPO in obese women (AUC = 0.64, p = 0.024). Furthermore, CPR was predictive for OD for IFC not only in obese (AUC = 0.72, p = 0.023) but also in non-obese (AUC = 0.61, p = 0.003) women.

Conclusions: Low CPR MoM was predictive for CAPO and OD for IFC in obese women without additional risk factors. However, the overall predictive performance of CPR for CAPO in obese women was poor.

目的评估与非肥胖产妇相比,肥胖产妇的脑-胎盘比率(CPR)在预测围产期综合不良结局(CAPO)方面的性能:这是一项在一家三级转诊中心进行的回顾性队列研究,为期 3 年。所有心肺复苏测量值≥37+0 周、估计胎儿体重≥10th 百分位数且尝试过阴道分娩的单胎妊娠均被纳入研究,并按孕前体重指数(BMI)2 将其分为两组。以下至少一项结果参数被定义为 CAPO:因产时胎儿受损(IFC)导致的手术分娩(OD)、入住新生儿重症监护室、脐带动脉 pH ≤ 7.15、5 分钟 Apgar 结果:研究队列包括 1207 名孕妇,其中 112 名孕妇的体重指数(BMI)≥ 30 kg/m 2 。肥胖产妇中发生 CAPO 的有 21 例(18.8%),而体重指数为 2 的产妇有 247 例(22.6%)(p = 0.404)。在整个研究队列中,CAPO 组和 IFC OD 组的 CPR MoM 明显较低。ROC 分析显示,低 CPR MoM 对肥胖妇女的 CAPO 有显著的预测价值(AUC = 0.64,p = 0.024)。此外,不仅在肥胖(AUC = 0.72,p = 0.023)妇女中,在非肥胖(AUC = 0.61,p = 0.003)妇女中,心肺复苏对 IFC 的 OD 也有预测作用:结论:在没有其他风险因素的肥胖女性中,低 CPR MoM 可预测 CAPO,OD 可预测 IFC。然而,CPR 对肥胖女性 CAPO 的总体预测性能较差。
{"title":"Value of Cerebroplacental Ratio in Predicting Adverse Perinatal Outcome in Term Pregnancies Complicated by Obesity.","authors":"Gabriel Eisenkolb, Anne Karge, Javier U Ortiz, Eva Ostermayer, Silvia M Lobmaier, Bettina Kuschel, Oliver Graupner","doi":"10.1055/a-2373-0722","DOIUrl":"https://doi.org/10.1055/a-2373-0722","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the performance of cerebroplacental ratio (CPR) in predicting composite adverse perinatal outcome (CAPO) in women with obesity compared to non-obese women at term.</p><p><strong>Methods: </strong>This is a retrospective cohort study in a single tertiary referral centre over a 3-year period. All singleton pregnancies with CPR measurements ≥ 37 + 0 weeks and estimated fetal weight ≥ 10 <sup>th</sup> centile and attempted vaginal delivery were included and divided into two groups defined by pre-pregnancy body mass index (BMI) </≥ 30 kg/m <sup>2</sup> . The presence of at least one of the following outcome parameters was defined as CAPO: operative delivery (OD) due to intrapartum fetal compromise (IFC), admission to the neonatal intensive care unit, umbilical cord arterial pH ≤ 7.15, 5 min Apgar < 7. The prognostic performance of CPR MoM was evaluated using receiver operating characteristic (ROC) analysis.</p><p><strong>Results: </strong>The study cohort included 1207 pregnancies, of which 112 were women with a BMI ≥ 30 kg/m <sup>2</sup> . In obese women, CAPO occurred in 21 cases (18.8%) compared to 247 (22.6%) cases in women with BMI < 30 kg/m <sup>2</sup> (p = 0.404). In the entire study cohort, CPR MoM was significantly lower in the CAPO and OD for IFC group. ROC analyses revealed a significant predictive value of low CPR MoM for CAPO in obese women (AUC = 0.64, p = 0.024). Furthermore, CPR was predictive for OD for IFC not only in obese (AUC = 0.72, p = 0.023) but also in non-obese (AUC = 0.61, p = 0.003) women.</p><p><strong>Conclusions: </strong>Low CPR MoM was predictive for CAPO and OD for IFC in obese women without additional risk factors. However, the overall predictive performance of CPR for CAPO in obese women was poor.</p>","PeriodicalId":12481,"journal":{"name":"Geburtshilfe Und Frauenheilkunde","volume":"84 11","pages":"1057-1065"},"PeriodicalIF":2.4,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11543107/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142618265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anxiety in Endometriosis Patients: Implications for Clinical Practice. 子宫内膜异位症患者的焦虑:对临床实践的影响。
IF 2.4 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-22 eCollection Date: 2024-12-01 DOI: 10.1055/a-2360-4604
Tomas Kupec, Rebecca Caspers, Philipp Meyer-Wilmes, Laila Najjari, Elmar Stickeler, Julia Wittenborn

Introduction: Endometriosis is a chronic disease associated with pain that affects at least 10% of all women of reproductive age. The symptoms of endometriosis have a negative impact on quality of life; they limit the patient physically and psychologically and are the cause of significant anxiety. The aim of our study was to investigate the anxiety levels of women presenting to our specialized endometriosis outpatient clinic at the RWTH Aachen University Hospital. We sought to record their anxiety symptoms and investigate the effect of extensive counseling on anxiety in patients with endometriosis. We hypothesized that detailed counseling and the planning of multimodal endometriosis therapy would reduce anxiety.

Material and methods: Data from 183 patients with lower abdominal pain or suspected endometriosis were analyzed. Prior to the examination, the patients completed a standardized anamnesis form including the German version of the STAI (State Trait Anxiety Inventory). The diagnosis of endometriosis was made in accordance with the recent ESHRE guideline and was based on anamnesis, gynecological examination, and ultrasound by a specialist senior physician with many years of experience in treating endometriosis.

Results: Prior to the medical examination, we observed a mean STAI-State score of 48.44 ± 11.56 and STAI-Trait score 45.68 ± 11.27. Following medical examination and planning of multimodal therapy, there was a significant decrease in the mean STAI-State score from 48.44 ± 11.56 to 42.43 ± 10.01 (p < 0.0001) and a minimal but significant decrease in the mean STAI-Trait score from 45.68 ± 11.27 to 45.01 ± 11.57 (p < 0.05).

Conclusion: Our study showed that endometriosis is associated with high levels of anxiety. Detailed counseling and the planning of a multimodal therapy led to a significant improvement in anxiety levels.

简介子宫内膜异位症是一种伴有疼痛的慢性疾病,至少影响 10%的育龄妇女。子宫内膜异位症的症状会对患者的生活质量产生负面影响;这些症状会限制患者的身心健康,并导致患者产生严重焦虑。我们的研究旨在调查亚琛工业大学医院子宫内膜异位症专科门诊就诊妇女的焦虑程度。我们试图记录她们的焦虑症状,并研究广泛的心理咨询对子宫内膜异位症患者焦虑的影响。我们假设,详细的咨询和多模式子宫内膜异位症治疗计划将减轻焦虑:分析了 183 名下腹疼痛或疑似子宫内膜异位症患者的数据。检查前,患者填写了一份标准化的病史表,其中包括德国版的 STAI(状态特质焦虑量表)。子宫内膜异位症的诊断是根据最新的 ESHRE 指南做出的,并由一位在治疗子宫内膜异位症方面有多年经验的资深专科医生根据病史、妇科检查和超声波检查做出诊断:体检前,我们观察到患者的平均 STAI-State 评分为 48.44 ± 11.56,STAI-Trait 评分为 45.68 ± 11.27。在体检和多模式治疗计划之后,STAI-State 平均得分从 48.44 ± 11.56 显著下降到 42.43 ± 10.01(p 结论:STAI-State 和 STAI-Trait 平均得分的下降与子宫内膜异位症的发病率有关:我们的研究表明,子宫内膜异位症与高度焦虑有关。详细的咨询和多模式疗法计划可显著改善焦虑水平。
{"title":"Anxiety in Endometriosis Patients: Implications for Clinical Practice.","authors":"Tomas Kupec, Rebecca Caspers, Philipp Meyer-Wilmes, Laila Najjari, Elmar Stickeler, Julia Wittenborn","doi":"10.1055/a-2360-4604","DOIUrl":"10.1055/a-2360-4604","url":null,"abstract":"<p><strong>Introduction: </strong>Endometriosis is a chronic disease associated with pain that affects at least 10% of all women of reproductive age. The symptoms of endometriosis have a negative impact on quality of life; they limit the patient physically and psychologically and are the cause of significant anxiety. The aim of our study was to investigate the anxiety levels of women presenting to our specialized endometriosis outpatient clinic at the RWTH Aachen University Hospital. We sought to record their anxiety symptoms and investigate the effect of extensive counseling on anxiety in patients with endometriosis. We hypothesized that detailed counseling and the planning of multimodal endometriosis therapy would reduce anxiety.</p><p><strong>Material and methods: </strong>Data from 183 patients with lower abdominal pain or suspected endometriosis were analyzed. Prior to the examination, the patients completed a standardized anamnesis form including the German version of the STAI (State Trait Anxiety Inventory). The diagnosis of endometriosis was made in accordance with the recent ESHRE guideline and was based on anamnesis, gynecological examination, and ultrasound by a specialist senior physician with many years of experience in treating endometriosis.</p><p><strong>Results: </strong>Prior to the medical examination, we observed a mean STAI-State score of 48.44 ± 11.56 and STAI-Trait score 45.68 ± 11.27. Following medical examination and planning of multimodal therapy, there was a significant decrease in the mean STAI-State score from 48.44 ± 11.56 to 42.43 ± 10.01 (p < 0.0001) and a minimal but significant decrease in the mean STAI-Trait score from 45.68 ± 11.27 to 45.01 ± 11.57 (p < 0.05).</p><p><strong>Conclusion: </strong>Our study showed that endometriosis is associated with high levels of anxiety. Detailed counseling and the planning of a multimodal therapy led to a significant improvement in anxiety levels.</p>","PeriodicalId":12481,"journal":{"name":"Geburtshilfe Und Frauenheilkunde","volume":"84 12","pages":"1150-1156"},"PeriodicalIF":2.4,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11624000/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142794582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sleep Disorders in Women: What Should a Gynecologist Know? 女性睡眠障碍:妇科医生应该知道什么?
IF 2.4 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-15 eCollection Date: 2024-11-01 DOI: 10.1055/a-2371-0763
Alperen Aksan, Berna Dilbaz

Women often face sleep disturbances during key life stages such as adolescence, pregnancy, postpartum period, and perimenopause, influenced by hormonal fluctuations and conditions like polycystic ovary syndrome (PCOS) and premenstrual syndrome (PMS). The goal is to explore women's sleep disorders as classified in the International Classification of Sleep Disorders-3 (ICSD-3). Through a literature review, this study assesses the management of sleep disorders in women, particularly focusing on the link between gynecological disease and sleep disorders. It scrutinizes landmark research in diagnosing and treating women's sleep disorders. Observations indicate that physiological changes during adolescence, pregnancy, postpartum, and perimenopause can cause sleep issues, commonly addressed by gynecologists. Conditions like PCOS and PMS are notably linked to increased sleep disorder occurrences. The conclusion underscores the importance of gynecologists' awareness of the heightened risk of sleep disturbances in women, who often present these issues during consultations.

受荷尔蒙波动以及多囊卵巢综合症(PCOS)和经前期综合症(PMS)等疾病的影响,女性在青春期、妊娠期、产后和围绝经期等人生关键阶段经常面临睡眠障碍。本研究的目的是探讨《国际睡眠障碍分类-3》(ICSD-3)中对女性睡眠障碍的分类。通过文献综述,本研究对女性睡眠障碍的管理进行了评估,尤其关注妇科疾病与睡眠障碍之间的联系。它仔细研究了在诊断和治疗女性睡眠障碍方面具有里程碑意义的研究。观察结果表明,青春期、妊娠期、产后和围绝经期的生理变化会导致睡眠问题,妇科医生通常会解决这些问题。多囊卵巢综合症和经前综合症等疾病与睡眠障碍发生率的增加有着明显的联系。这一结论强调了妇科医生意识到女性睡眠障碍风险增加的重要性,因为她们经常在就诊时提出这些问题。
{"title":"Sleep Disorders in Women: What Should a Gynecologist Know?","authors":"Alperen Aksan, Berna Dilbaz","doi":"10.1055/a-2371-0763","DOIUrl":"https://doi.org/10.1055/a-2371-0763","url":null,"abstract":"<p><p>Women often face sleep disturbances during key life stages such as adolescence, pregnancy, postpartum period, and perimenopause, influenced by hormonal fluctuations and conditions like polycystic ovary syndrome (PCOS) and premenstrual syndrome (PMS). The goal is to explore women's sleep disorders as classified in the International Classification of Sleep Disorders-3 (ICSD-3). Through a literature review, this study assesses the management of sleep disorders in women, particularly focusing on the link between gynecological disease and sleep disorders. It scrutinizes landmark research in diagnosing and treating women's sleep disorders. Observations indicate that physiological changes during adolescence, pregnancy, postpartum, and perimenopause can cause sleep issues, commonly addressed by gynecologists. Conditions like PCOS and PMS are notably linked to increased sleep disorder occurrences. The conclusion underscores the importance of gynecologists' awareness of the heightened risk of sleep disturbances in women, who often present these issues during consultations.</p>","PeriodicalId":12481,"journal":{"name":"Geburtshilfe Und Frauenheilkunde","volume":"84 11","pages":"1043-1049"},"PeriodicalIF":2.4,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11543111/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142618263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contrast Hysterosonographic Evaluation of Niche Prevalence Following a Standardized Suturing Technique for Caesarean Sections. 剖腹产标准化缝合技术后宫腔粘连率的对比子宫超声评估
IF 2.4 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-06 eCollection Date: 2024-08-01 DOI: 10.1055/a-2341-4586
Anita Hafner, Marie Christine Pohle, Maximilian Rauh, Annegret Schnabel, Sylvia Meyer, Angela Köninger

Introduction: After caesarean section a uterine niche can be detected in 42-84% of all women and in 11-45% large defects with a residual myometrium < 2.2 mm occur. If the niche compromises > 50% of myometrial thickness, risk of uterine rupture during birth increases. The suturing technique might contribute substantially on pathogenesis of niches. The objective of this study is to investigate the effect of the suturing technique on niche prevalence by using a standardized two-layer surgical technique.

Methods: Women with one previous caesarean section were examined within 6-23 months after caesarean section using contrast medium-supported transvaginal sonography regarding the prevalence, sonomorphological aspect and clinical symptoms of a uterine niche. The surgical technique used was: dilatation of the cervix, interrupted suture of the first layer (excluding the endometrium), continuous closure of the visceral and parietal peritoneum.

Results: Using native vaginal sonography, no niches were visible in the whole cohort. In three cases, there was a small niche detectable with a depth between 2.3 and 3.9 mm by contrast hysterosonography. Regarding the total myometrial thickness, the niche depth compromised less than 50%. All patients were symptom-free.

Conclusion: In our study population, there were only three cases (9.1%) with a small uterine niche. Residual myometrium and niche percentage on myometrial thickness were excellent in all three cases. Thus, our results show that the uterotomy closure technique used in the study cohort might be superior with respect to the development of uterine niches compared with the expected prevalence.

导言:在剖腹产手术后,42%-84%的产妇会出现子宫龛,11%-45%的大缺损产妇会出现残留子宫肌厚度为子宫肌厚度 50%的子宫龛,分娩时子宫破裂的风险会增加。缝合技术可能会对龛影的发病机制产生重大影响。本研究的目的是通过使用标准化的两层手术技术,研究缝合技术对龛影发生率的影响:方法:使用造影剂支持的经阴道超声波检查剖腹产术后 6-23 个月内曾进行过一次剖腹产的妇女的子宫龛的发生率、声像图和临床症状。采用的手术方法是:扩张宫颈,间断缝合第一层(不包括子宫内膜),连续缝合内脏和腹膜旁:通过阴道超声检查,所有病例均未发现龛影。在三个病例中,通过造影剂子宫超声检查发现了一个深度在 2.3 至 3.9 毫米之间的小龛。就子宫肌层的总厚度而言,龛影深度不足 50%。所有患者均无症状:在我们的研究人群中,只有三例(9.1%)患者的子宫龛较小。结论:在我们的研究人群中,只有三例(9.1%)子宫龛较小,所有三例患者的残余子宫肌层和子宫龛占子宫肌层厚度的比例都非常好。因此,我们的研究结果表明,与预期的发生率相比,本研究中使用的子宫切口闭合技术在子宫龛的形成方面可能更胜一筹。
{"title":"Contrast Hysterosonographic Evaluation of Niche Prevalence Following a Standardized Suturing Technique for Caesarean Sections.","authors":"Anita Hafner, Marie Christine Pohle, Maximilian Rauh, Annegret Schnabel, Sylvia Meyer, Angela Köninger","doi":"10.1055/a-2341-4586","DOIUrl":"10.1055/a-2341-4586","url":null,"abstract":"<p><strong>Introduction: </strong>After caesarean section a uterine niche can be detected in 42-84% of all women and in 11-45% large defects with a residual myometrium < 2.2 mm occur. If the niche compromises > 50% of myometrial thickness, risk of uterine rupture during birth increases. The suturing technique might contribute substantially on pathogenesis of niches. The objective of this study is to investigate the effect of the suturing technique on niche prevalence by using a standardized two-layer surgical technique.</p><p><strong>Methods: </strong>Women with one previous caesarean section were examined within 6-23 months after caesarean section using contrast medium-supported transvaginal sonography regarding the prevalence, sonomorphological aspect and clinical symptoms of a uterine niche. The surgical technique used was: dilatation of the cervix, interrupted suture of the first layer (excluding the endometrium), continuous closure of the visceral and parietal peritoneum.</p><p><strong>Results: </strong>Using native vaginal sonography, no niches were visible in the whole cohort. In three cases, there was a small niche detectable with a depth between 2.3 and 3.9 mm by contrast hysterosonography. Regarding the total myometrial thickness, the niche depth compromised less than 50%. All patients were symptom-free.</p><p><strong>Conclusion: </strong>In our study population, there were only three cases (9.1%) with a small uterine niche. Residual myometrium and niche percentage on myometrial thickness were excellent in all three cases. Thus, our results show that the uterotomy closure technique used in the study cohort might be superior with respect to the development of uterine niches compared with the expected prevalence.</p>","PeriodicalId":12481,"journal":{"name":"Geburtshilfe Und Frauenheilkunde","volume":"84 8","pages":"737-746"},"PeriodicalIF":2.4,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11303011/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141901495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Geburtshilfe Und Frauenheilkunde
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1